Showing 1 - 11 results of 11 for search 'Ezra E. W. Cohen', query time: 0.04s
Refine Results
-
1
Current perspectives on recurrent HPV-mediated oropharyngeal cancer by Theresa Guo, Stephen Y. Kang, Ezra E. W. Cohen
Published 2022-08-01
Article -
2
-
3
p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitors. by Wen-Liang Kuo, Marina N Sharifi, Mark W Lingen, Omar Ahmed, Jing Liu, Madhavi Nagilla, Kay F Macleod, Ezra E W Cohen
Published 2014-01-01
Article -
4
Human papillomavirus E5 suppresses immunity via inhibition of the immunoproteasome and STING pathway by Sayuri Miyauchi, Sangwoo S. Kim, Riley N. Jones, Lin Zhang, Kripa Guram, Sonia Sharma, Stephen P. Schoenberger, Ezra E.W. Cohen, Joseph A. Califano, Andrew B. Sharabi
Published 2023-05-01
Article -
5
Method for estimation of apoptotic cell fraction of cytotherapy using in vivo fluorine-19 magnetic resonance: pilot study in a patient with head and neck carcinoma receiving tumor-... by Gregory A Daniels, Brooke M Helfer, Eric T Ahrens, Karen Messer, Hongyan Xu, Charles F O’Hanlon, Deanne R Lister, Julie L Bykowski, Benjamin I Leach, Jiawen Chen, Ezra E W Cohen
Published 2023-06-01
Article -
6
Programmed death 1 (PD‐1) and ligand (PD‐L1) inhibitors in head and neck squamous cell carcinoma: A meta‐analysis by Dylan A. Levy, Jaimin J. Patel, Shaun A. Nguyen, W. Nicholas Jungbauer, David M. Neskey, Ezra E. W. Cohen, Chrystal M. Paulos, John A. Kaczmar, Hannah M. Knochelmann, Terry A. Day
Published 2022-09-01
Article -
7
Tumor cells fail to present MHC-II–restricted epitopes derived from oncogenes to CD4+ T cells by Spencer E. Brightman, Martin S. Naradikian, Rukman R. Thota, Angelica Becker, Leslie Montero, Milad Bahmanof, Ashmitaa Logandha Ramamoorthy Premlal, Jason A. Greenbaum, Bjoern Peters, Ezra E.W. Cohen, Aaron M. Miller, Stephen P. Schoenberger
Published 2023-01-01
Article -
8
Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression by Joseph S. Dolina, Joey Lee, Spencer E. Brightman, Sara McArdle, Samantha M. Hall, Rukman R. Thota, Karla S. Zavala, Manasa Lanka, Ashmitaa Logandha Ramamoorthy Premlal, Jason A. Greenbaum, Ezra E. W. Cohen, Bjoern Peters, Stephen P. Schoenberger
Published 2023-09-01
Article -
9
Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy by Dina V. Hingorani, Michael M. Allevato, Maria F. Camargo, Jacqueline Lesperance, Maryam A. Quraishi, Joseph Aguilera, Ida Franiak-Pietryga, Daniel J. Scanderbeg, Zhiyong Wang, Alfredo A. Molinolo, Diego Alvarado, Andrew B. Sharabi, Jack D. Bui, Ezra E. W. Cohen, Stephen R. Adams, J. Silvio Gutkind, Sunil J. Advani
Published 2022-07-01
Article -
10
Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC by Robert Saddawi-Konefka, Aoife O’Farrell, Farhoud Faraji, Lauren Clubb, Michael M. Allevato, Shawn M. Jensen, Bryan S. Yung, Zhiyong Wang, Victoria H. Wu, Nana-Ama Anang, Riyam Al Msari, Shiruyeh Schokrpur, Ida Franiak Pietryga, Alfredo A. Molinolo, Jill P. Mesirov, Aaron B. Simon, Bernard A. Fox, Jack D. Bui, Andrew Sharabi, Ezra E. W. Cohen, Joseph A. Califano, J. Silvio Gutkind
Published 2022-07-01
Article -
11
Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study by Howard L McLeod, A Dimitrios Colevas, Georges Azzi, Kevin C Flanagan, Douglas Adkins, Jessica Ley, Ezra E W Cohen, James Wade, Jon Earls, Jeffrey Hiken, Rachel L Wellinghoff, Michelle M Ponder, William H Westra, Vera Vavinskaya, Leisa Sutton, Ida Deichaite, Orlan K Macdonald, Karim Welaya, Andrew W Pippas, Jennifer Slim, Bruce Bank, Xingwei Sui, Steven E Kossman, Todd D Shenkenberg, Warren L Alexander, Katharine A Price, David N Messina, Jarret I Glasscock, Eric J Duncavage
Published 2024-11-01
Article